medigraphic.com
ISSN 2078-7170 (Electronic)

2022, Number 4

<< Back Next >>

CorSalud 2022; 14 (4)

Does vitamin D prevent atherosclerosis?

Fajardo QAJ, Licea González MÁ

Language: Spanish
References: 27
Page: 375-379
PDF size: 233.87 Kb.


ABSTRACT

Atherosclerosis is a progressive inflammatory systemic disease that mainly affects the wall of large and medium-sized arteries. Vitamin D can stop or prevent several triggering factors of this disease and its use has been proposed to prevent it. Hypo-vitaminosis D is related to diseases that are triggering or aggravating factors of ath-erosclerosis. The use of vitamin D as a prophylactic measure to treat atherosclerosis should theoretically work, which is why large studies have been done to prove this theory. The large controlled researches have evidenced its positive effect on the prevention of triggering factors, but not on atherosclerosis, something that could be contradictory. A review of the most recent literature on the subject was carried out with the aim of describing the role of vitamin D in the prevention of atherosclerosis.


REFERENCES

  1. Ruiz-León AM, Lapuente M, Estruch R, Casas R. Clinical Advances in Immunonutrition and Ather-osclerosis: A Review. Front Immunol [Internet]. 2019 [citado 11 Dic 2021];10:837. Disponible en: https://doi.org/10.3389/fimmu.2019.00837

  2. Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD. Targeting Early Athero-sclerosis: A Focus on Oxidative Stress and Inflam-mation. Oxid Med Cell Longev [Internet]. 2019 [ci-tado 11 Dic 2021];2019:8563845. Disponible en: https://doi.org/10.1155/2019/8563845

  3. Olmedo-Martín RV, González-Molero I, Olveira G, Amo-Trillo V, Jiménez-Pérez M. Exposición solar en la enfermedad inflamatoria intestinal ambulato-ria: factores predictivos y correlación con la con-centración sérica de vitamina D. Gastroenterol He-patol. 2019;42(10):604-13. [DOI]

  4. Sanz R, Mazzei L, Santino N, Ingrasia M, Manucha W. La interacción vitamina D-mitocondria podría modular el camino de señalización involucrado en el desarrollo de la hipertensión: una visión integra-tiva translacional. Clin Investig Arterioscler. 2020; 32(4):144-55. [DOI]

  5. Lupoli R, Vaccaro A, Ambrosino P, Poggio P, Ama-to M, Di Minno MN. Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: a pooled analysis of cohort studies. J Clin Endocrinol Me-tab. 2017;102(7):2146-53. [DOI]

  6. Aquila G, Marracino L, Martino V, Calabria D, Cam-po G, Caliceti C, Rizzo P. The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway. Oxid Med Cell Longev [Internet]. 2019 [citado 15 Dic 2021];2019:5470470. [DOI]

  7. Hsu S, Hoofnagle AN, Gupta DK, Gutierrez OM, Peralta CA, Shea S, et al. Race, Ancestry, and Vita-min D Metabolism: The Multi-Ethnic Study of Ath-erosclerosis. J Clin Endocrinol Metab. 2020;105(12): e4337–50. [DOI]

  8. Bennett AL, Lavie CJ. Vitamin D Metabolism and the Implications for Atherosclerosis. Adv Exp Med Biol. 2017;996:185-92. [DOI]

  9. Malekmohammad K, Sewell RDE, Rafieian-Kopaei M. Antioxidants and Atherosclerosis: Mechanistic Aspects. Biomolecules [Internet]. 2019 [citado 15 Dic 2021];9(8):301. Disponible en: https://doi.org/10.3390/biom9080301

  10. Zhu Y, Xian X, Wang Z, Bi Y, Chen Q, Han X, et al. Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules [Internet]. 2018 [citado 18 Dic 2021];8(3):80. Dispo-nible en: https://doi.org/10.3390/biom8030080

  11. Zhao TX, Mallat Z. Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(13):1691-706. [DOI]

  12. Hernández Puentes YZ, Fernández-Britto Rodrí-guez JE, Montero González T. Impacto del taba-quismo en la aterosclerosis coronaria de fallecidos por muerte violenta. Rev Cuban Med Mil [Inter-net]. 2018 [citado 22 Dic 2021];47(4):369-79. Dis-po-nible en: https://revmedmilitar.sld.cu/in-dex.php/mil/article/view/202/245

  13. Kim HL, Kim SH. Pulse Wave Velocity in Atherosclerosis. Front Cardiovasc Med [Internet]. 2019 [citado 22 Dic 2021];6:41. Disponible en: https://doi.org/10.3389/fcvm.2019.00041

  14. González Casanova JM, Valdés Chávez RC, Álva-rez Gómez AE, Toirac Delgado K, Casanova Mo-reno MC. Factores de riesgo de aterosclerosis en adultos diabéticos de un consultorio médico. Univ Méd Pinareña [Internet]. 2018 [citado 27 Dic 2021];14(2):121-8. Disponible en: https://rev-galeno.sld.cu/index.php/ump/article/view/278

  15. Rashidi B, Hoseini Z, Sahebkar A, Mirzaei H. Anti-Atherosclerotic Effects of Vitamins D and E in Sup-pression of Atherogenesis. J Cell Physiol. 2017; 232(11):2968-76. [DOI]

  16. Guzmán C, Fredes P, Manterola C. Relación entre inflamación crónica asociada a obesidad y déficit de vitamina D. Rev Chil Nutr. 2019;46(5):622-5. [DOI]

  17. Hiemstra TF, Lim K, Thadhani R, Manson JE. Vita-min D and Atherosclerotic Cardiovascular Dis-ease. J Clin Endocrinol Metab. 2019;104(9):4033-50. [DOI]

  18. Chen FH, Liu T, Xu L, Zhang L, Zhou XB. Associa-tion of Serum Vitamin D Level and Carotid Athe-rosclerosis: A Systematic Review and Meta-analy-sis. J Ultrasound Med. 2018;37(6):1293-303. [DOI]

  19. Driggin E, Madhavan MV, Gupta A. The role of vit-amin D in cardiovascular disease and COVID-19. Rev Endocr Metab Disord. 2022;23(2):293-7. [DOI]

  20. Bioti Torres Y, Navarro Despaigne DA, Acosta Ce-deño A. Vitamina D, más allá de la homeostasis cál-cica. Rev Cuba Endocrinol [Internet]. 2020 [citado 27 Dic 2021];31(2). Disponible en: https://revendo-crinologia.sld.cu/index.php/endocrinologia/arti-cle/view/183/234

  21. Mousa A, Naderpoor N, Teede H, Scragg R, de Courten B. Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2018;76(5):380-94. [DOI]

  22. Riccardi G, Giosuè A, Calabrese I, Vaccaro O. Die-tary recommendations for prevention of athero-sclerosis. Cardiovasc Res. 2022;118(5):1188-204. [DOI]

  23. Perez Ingles D, Cruz Rodriguez JB, Garcia H. Sup-plemental Vitamins and Minerals for Cardiovascu-lar Disease Prevention and Treatment. Curr Car-diol Rep [Internet]. 2020 [citado 4 Ene 2022];22(4): 22. Disponible en: https://doi.org/10.1007/s11886-020-1270-1

  24. Kim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS, et al. Association of Multivitamin and Mineral Supplementation and Risk of Cardio-vascular Disease: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes [Inter-net]. 2018 [citado 4 Ene 2022];11(7):e004224. Dispo-nible en: https://doi.org/10.1161/circoutco-mes.117.004224

  25. Manson JE, Bassuk SS, Cook NR, Lee IM, Mora S, Albert CM, et al. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence. Circ Res. 2020;126(1):112-8. [DOI]

  26. Orkaby AR, Djousse L, Manson JE. Vitamin D sup-plements and prevention of cardiovascular di-sease. Curr Opin Cardiol. 2019;34(6):700-5. [DOI]

  27. Greco D, Kocyigit D, Adorni MP, Marchi C, Ronda N, Bernini F, et al. Vitamin D replacement amelio-rates serum lipoprotein functions, adipokine pro-file and subclinical atherosclerosis in pre-meno-pausal women. Nutr Metab Cardiovasc Dis. 2018; 28(8):822-9. [DOI]




2020     |     www.medigraphic.com